TEVA PHARMACEUTICAL INDUSTRIES LTD
Insider activity for last month from Oct 16 to Nov 16.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
TEVA transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|
Daniell RichardExecutive Vice President · ECEVP, EC | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $0View disclosure → | |
Daniell RichardExecutive Vice President · ECEVP, EC | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $0View disclosure → | |
Daniell RichardExecutive Vice President · ECEVP, EC | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$856kView disclosure → | |
Daniell RichardExecutive Vice President · ECEVP, EC | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $694kView disclosure → | |
Daniell RichardExecutive Vice President · ECEVP, EC | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$1.07MView disclosure → | |
Daniell RichardExecutive Vice President · ECEVP, EC | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $868kView disclosure → | |
Francis Richard DPresidentPRES | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$10.6MView disclosure → | |
Sabag MarkSRSR | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $0View disclosure → | |
Sabag MarkSRSR | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$1.97MView disclosure → | |
Sabag MarkSRSR | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $1.56MView disclosure → | |
Weiss AmirCAOCAO. Role codes can represent multiple titles; the list does not include the filing title. | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $0View disclosure → | |
Weiss AmirCAOCAO. Role codes can represent multiple titles; the list does not include the filing title. | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$410kView disclosure → | |
Weiss AmirCAOCAO. Role codes can represent multiple titles; the list does not include the filing title. | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$305kView disclosure → | |
Weiss AmirCAOCAO. Role codes can represent multiple titles; the list does not include the filing title. | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$28.6kView disclosure → | |
Weiss AmirCAOCAO. Role codes can represent multiple titles; the list does not include the filing title. | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $269kView disclosure → | |
Bergwerk DovCLOCLO. Role codes can represent multiple titles; the list does not include the filing title. | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
Brailer David JDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
Sabag MarkSRSR | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $0View disclosure → | |
Sabag MarkSRSR | SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$1.93MView disclosure → | |
Sabag MarkSRSR | Option exerciseForm 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3. | $1.61MView disclosure → |
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Nov 12, 2026
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Nov 2026 | 0 | 10 | 2 | $0 | $18,230,009.49 | −$18,230,009.49 |
Distinct insiders active
Reporting-owner CIKs by month · peak Nov 2026 (6)Largest insider activity
By absolute net disclosed value · current transaction page- FD−$10.6M
- SM−$736k
- WA−$475k
- DR−$367k
- BD$0
Filing, role and holdings details
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period- M · Option exercise · dominant14 · 54%
- S · Open-market sells10 · 38%
- A · Grants / awards2 · 7.7%
Activity by reported role
A joint filing can contribute to multiple rolesReported Holdings After
Separated by insider, security, and ownership type
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redTEVA PHARMACEUTICAL INDUSTRIES LTD Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at TEVA PHARMACEUTICAL INDUSTRIES LTD?
Daniell Richard, Francis Richard D, Sabag Mark, Weiss Amir, Bergwerk Dov, BRAILER DAVID J.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Sabag Mark reported a sale on Nov 12, 2026 valued at $1.97M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $18,230,009.49. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.